Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The yeast regulatory gene
CAT3
has an essential function for the depression of several glucose-repressible enzymes. Therefore, cat3 mutants are unable to grow on maltose or on non-fermentable carbon sources. Unlike the point mutants isolated previously, cat3 null allele strains also failed to utilize raffinose or galactose as sole carbon sources. Sequencing of an 1.6-kb HindIII-BglII fragment complementing cat3 mutations revealed an open reading frame of 322 codons, size of which is in good agreement with the 1.3-kb size of mRNA. No significant similarities with previously sequenced genes could be detected.
CAT3
-lacZ fusions confirmed the proposed reading frame. A
CAT3
-lacZ fusion encoding 307 amino acids of
CAT3
was able to complement the growth defects of cat3 point mutants and null allele strains. Assay of
beta-galactosidase
activity under different growth conditions indicated a constitutive expression of the
CAT3
gene product. Cellular fractionation studies showed the nuclear localization of the
CAT3
protein.
...
PMID:Molecular characterization of yeast regulatory gene CAT3 necessary for glucose derepression and nuclear localization of its product. 304 55